Scotts Miracle-Gro (SMG) PT Lowered to $86 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SMG Hot Sheet
Price: $67.19 +8.72%
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
UBS analyst Peter Grom lowered the price target on Scotts Miracle-Gro (NYSE: SMG) to $86.00 (from $92.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Scotts Miracle-Gro (SMG) PT Raised to $71 at Wells Fargo, Assumes Overweight
- CVS Health (CVS) PT Lowered to $103 at Jefferies
- ScottsMiracle-Gro Reports Strong Fiscal 2026 Full-Year Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
